Gerry McGettigan
Président chez Aurum Biosciences Ltd.
Profil
Gerry McGettigan is the founder of GMG BioBusiness Ltd.
He is currently the Executive Chairman at Aurum Biosciences Ltd.
He was previously the Chief Executive Officer at Fundació Privada BioRegió de Catalunya, Non-Executive Chairman at Clear Surgical Ltd., Director-Regulatory & Scientific Affairs at The Liposome Co., Inc., Director at Biopta Ltd., Non-Executive Director at Syntropharma Ltd., Principal at Glaxo Holdings Plc, and Chief Operating Officer at Northern Data AG.
Postes actifs de Gerry McGettigan
| Sociétés | Poste | Début |
|---|---|---|
Aurum Biosciences Ltd.
 Aurum Biosciences Ltd. Medical DistributorsDistribution Services Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom. | Président | - |
Anciens postes connus de Gerry McGettigan
| Sociétés | Poste | Fin |
|---|---|---|
| NORTHERN DATA AG | Directeur des opérations | 13/03/2017 |
Clear Surgical Ltd.
 Clear Surgical Ltd. Medical SpecialtiesHealth Technology Clear Surgical Ltd. designs, develops and manufactures and wholesales disposable surgical instruments. Its products include Oplight and Cannulated Forceps. The company is headquartered in Larbert, the United Kingdom. | Président | 01/10/2015 |
GMG BioBusiness Ltd.
 GMG BioBusiness Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, GMG BioBusiness Ltd. is a British company that provides a comprehensive range of regulatory and product development consulting services. The company is based in Cambridge, UK. The company was founded by Gerry McGettigan. GMG BioBusiness was acquired by PRA Health Sciences, Inc., part of ICON plc from July 01, 2021. | Fondateur | - |
| Fundació Privada BioRegió de Catalunya | President | - |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NORTHERN DATA AG | Technology Services |
| Entreprise privées | 8 |
|---|---|
Syntropharma Ltd.
 Syntropharma Ltd. Pharmaceuticals: MajorHealth Technology Syntropharma Ltd. produces and distributes pharmaceutical products. It specializes in the development of the skin patches of proven medicines targeting diseases affecting the central nervous system. The company was founded by Andrew Gardiner and David McHoul on February 1, 2005 and is headquartered in Newtown St Boswells, the United Kingdom. | Health Technology |
| Glaxo Holdings Plc | Finance |
Biopta Ltd.
 Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Commercial Services |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
GMG BioBusiness Ltd.
GMG BioBusiness Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, GMG BioBusiness Ltd. is a British company that provides a comprehensive range of regulatory and product development consulting services. The company is based in Cambridge, UK. The company was founded by Gerry McGettigan. GMG BioBusiness was acquired by PRA Health Sciences, Inc., part of ICON plc from July 01, 2021. | Commercial Services |
| Fundació Privada BioRegió de Catalunya | |
Aurum Biosciences Ltd.
Aurum Biosciences Ltd. Medical DistributorsDistribution Services Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom. | Distribution Services |
Clear Surgical Ltd.
Clear Surgical Ltd. Medical SpecialtiesHealth Technology Clear Surgical Ltd. designs, develops and manufactures and wholesales disposable surgical instruments. Its products include Oplight and Cannulated Forceps. The company is headquartered in Larbert, the United Kingdom. | Health Technology |
